s6y

Receptos, Inc.

CIK
1463729
Industry
Pharmaceutical Preparations
Formerly
Receptos, Inc. (f.k.a. Receptor Pharmaceuticals Inc.)

Financials 10

  1. 10-Q Quarterly Report for period ending Jun 30, 2015
  2. 10-Q Quarterly Report for period ending Mar 31, 2015
  3. 10-K Annual Report for period ending Dec 31, 2014
  4. 10-Q Quarterly Report for period ending Sep 30, 2014
  5. 10-Q Quarterly Report for period ending Jun 30, 2014
  6. 10-Q Quarterly Report for period ending Mar 31, 2014
  7. 10-K Annual Report for period ending Dec 31, 2013
  8. 10-Q Quarterly Report for period ending Sep 30, 2013
  9. 10-Q Quarterly Report for period ending Jun 30, 2013
  10. 10-Q Quarterly Report for period ending Mar 31, 2013

News 34

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 34 news filings

Ownership 162

  1. SC 13G/A Major Shareholders
  2. SC 13G/A Major Shareholders
  3. 3 Initial statement of beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 162 ownership filings

Prospectus 33

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. SC TO-T/A Third party tender offer statement
  4. SC TO-T/A Third party tender offer statement
  5. SC TO-T/A Third party tender offer statement
  6. SC TO-T Third party tender offer statement
  7. SC TO-C Written communication relating to an issuer or third party tender offer
  8. SC TO-C Written communication relating to an issuer or third party tender offer
  9. SC TO-C Written communication relating to an issuer or third party tender offer
  10. SC TO-C Written communication relating to an issuer or third party tender offer

All 33 prospectus filings

Proxies 4

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements

Other 34

  1. 15-12B Notice of termination of registration of a class of securities under Section 12(b)
  2. EFFECT Notice of Effectiveness
  3. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  4. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  5. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  6. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  7. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  8. SC 14D9 Tender offer solicitation/recommendation statements filed under Rule 14d-9
  9. SC14D9C Written communication by the subject company relating to a third party tender offer
  10. CT ORDER Order Granting Confidential Treatment

All 34 other filings